Back to FDA Applications sponsored by PHARMACIA AND UPJOHN

FDA Drug Application 021106 by PHARMACIA AND UPJOHN

Application Number021106
Application Type New Drug Application
Sponsor ApplicantPHARMACIA AND UPJOHN
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan CodeV


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP03/25/2003N4464000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21106_somavert_lbl.pdf 3/25/2003
AP03/25/2003N4666000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21106ltr.pdf 3/28/2003
AP03/25/2003N6011000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021106_somavert.cfm 6/25/2003
AP08/18/2008SLR20649015   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021106s015ltr.pdf 8/20/2008
AP08/18/2008SLR20674015   http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021106s015lbl.pdf 8/26/2008
AP07/20/2010SLR25996028   http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021106s028lbl.pdf 7/22/2010
AP07/20/2010SLR26003028   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021106s028ltr.pdf 7/23/2010
AP07/3/2012SLR33195031   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021106s031lbl.pdf 7/13/2012
AP012/10/2013SE838016036   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021106s036lbl.pdf 12/12/2013
AP012/10/2013SE838022036   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021106Orig1s036ltr.pdf 12/13/2013
AP03/1/2013SCM       
AP09/26/2013SCM       
AP010/11/2013SCM       
AP07/31/2014SCM       
AP02/22/2016SCM       
AP01/11/2016SCM       
AP04/22/2016SCM       
AP08/15/2016SCM       




Back to FDA Applications sponsored by PHARMACIA AND UPJOHN

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.